The main strategies currently used for treating advanced melanoma include targeted therapies (e.g. BRAF inhibitors, such as vemurafenib) and immunotherapy (e.g. anti-CTLA-4 antibodies, such as ipilimumab) [5]. The gene discussed is BRAF; the disease is melanoma.